995247940	995247940	CD	B-NP	O
|	|	NN	I-NP	O
NPCH	NPCH	NN	I-NP	O
|	|	NN	I-NP	O
01328259	01328259	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
9990314	9990314	CD	B-NP	O
|	|	CC	I-NP	O
6/26/2007	6/26/2007	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
rheumatoid	rheumatoid	JJ	I-NP	O
arthritis	arthritis	NN	I-NP	O
|	|	NN	I-NP	O
Unsigned	Unsigned	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/4/2007	7/4/2007	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Unsigned	Unsigned	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/27/2007	5/27/2007	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
BOLINGER	BOLINGER	NN	B-NP	O
,	,	,	O	O
TERRENCE	TERRENCE	NNP	B-NP	O
M.D.	M.D.	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
responsible	responsible	JJ	B-ADJP	O
for	for	IN	B-PP	O
causing	cause	VBG	B-VP	O
the	the	DT	B-NP	O
admission	admission	NN	I-NP	O
is	be	VBZ	B-VP	O
rheumatoid	rheumatoid	JJ	B-NP	O
arthritis	arthritis	NN	I-NP	O
flare	flare	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
65-year-old	65-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
rheumatoid	rheumatoid	NN	B-NP	O
and	and	CC	I-NP	O
gouty	gouty	NN	I-NP	O
arthritis	arthritis	NN	I-NP	O
,	,	,	O	O
insulin-dependent	insulin-dependent	JJ	B-NP	O
diabetes	diabete	NNS	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
sickle	sickle	NN	B-NP	O
cell	cell	NN	I-NP	O
trait	trait	NN	I-NP	O
and	and	CC	O	O
chronic	chronic	JJ	B-NP	O
kidney	kidney	NN	I-NP	O
disease	disease	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
baseline	baseline	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
1.9	1.9	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
her	her	PRP$	B-NP	O
rheumatoid	rheumatoid	NN	I-NP	O
and	and	CC	I-NP	O
gouty	gouty	NN	I-NP	O
arthritis	arthritis	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
long	long	RB	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
methotrexate	methotrexate	NN	B-NP	O
and	and	CC	I-NP	O
allopurinol	allopurinol	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
5/3	5/3	CD	B-NP	O
,	,	,	O	O
due	due	JJ	B-PP	O
to	to	TO	B-PP	O
worsening	worsen	VBG	B-VP	O
renal	renal	JJ	B-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
methotrexate	methotrexate	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

Following	Follow	VBG	B-PP	O
this	this	DT	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
her	her	PRP$	B-NP	O
rheumatologist	rheumatologist	NN	I-NP	O
with	with	IN	B-PP	O
complaints	complaint	NNS	B-NP	O
of	of	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
joint	joint	JJ	B-NP	O
pains	pain	NNS	I-NP	O
and	and	CC	O	O
body	body	NN	B-NP	O
aches	ache	NNS	I-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Plaquenil	Plaquenil	NN	B-NP	O
on	on	IN	B-PP	O
7/25/07	7/25/07	CD	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
10/3/07	10/3/07	CD	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Ry	Ry	NNP	I-NP	O
And	And	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
Emergency	Emergency	NNP	I-NP	O
Department	Department	NNP	I-NP	O
complaining	complaining	NN	I-NP	O
of	of	IN	B-PP	O
total	total	JJ	B-NP	O
body	body	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
particular	particular	JJ	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
said	say	VBD	B-VP	O
that	that	IN	B-SBAR	O
her	her	PRP$	B-NP	O
left	left	JJ	I-NP	O
groin	groin	NN	I-NP	O
was	be	VBD	B-VP	O
very	very	RB	B-ADJP	O
painful	painful	JJ	I-ADJP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
when	when	WRB	B-ADVP	O
asked	ask	VBN	B-VP	O
,	,	,	O	O
she	she	PRP	B-NP	O
said	say	VBD	B-VP	O
that	that	IN	B-SBAR	O
every	every	DT	B-NP	O
joint	joint	NN	I-NP	O
and	and	CC	I-NP	O
muscle	muscle	NN	I-NP	O
group	group	NN	I-NP	O
was	be	VBD	B-VP	O
causing	cause	VBG	I-VP	O
discomfort	discomfort	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denied	deny	VBD	B-VP	O
fevers	fever	NNS	B-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
loose	loose	JJ	B-NP	O
stools	stool	NNS	I-NP	O
,	,	,	O	O
urinary	urinary	JJ	B-NP	O
symptoms	symptom	NNS	I-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
or	or	CC	O	O
other	other	JJ	B-NP	O
constitutional	constitutional	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
aside	aside	RB	B-ADVP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
headache	headache	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
pain	pain	NN	I-NP	O
especially	especially	RB	B-ADVP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
hip	hip	NN	I-NP	O
was	be	VBD	B-VP	O
so	so	RB	B-ADJP	O
severe	severe	JJ	I-ADJP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
that	that	IN	B-NP	O
she	she	PRP	B-NP	O
felt	feel	VBD	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
walk	walk	VB	I-VP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Rheumatoid	Rheumatoid	NN	B-NP	O
and	and	CC	I-NP	O
gouty	gouty	NN	I-NP	O
arthritis	arthritis	NN	I-NP	O
:	:	:	O	O
Previously	Previously	RB	B-ADVP	O
on	on	IN	B-PP	O
methotrexate	methotrexate	NN	B-NP	O
and	and	CC	I-NP	O
allopurinol	allopurinol	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
due	due	RB	B-ADVP	O
to	to	TO	B-PP	O
worsening	worsen	VBG	B-VP	O
renal	renal	JJ	B-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
methotrexate	methotrexate	NN	B-NP	O
was	be	VBD	B-VP	O
stopped	stop	VBN	I-VP	O
in	in	IN	B-PP	O
5/3	5/3	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Plaquenil	Plaquenil	NN	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
in	in	IN	B-PP	O
7/21	7/21	CD	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Insulin-dependent	Insulin-dependent	JJ	B-NP	O
diabetes	diabete	NNS	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Sickle	Sickle	NN	B-NP	O
cell	cell	NN	I-NP	O
trait	trait	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Multinodular	Multinodular	JJ	B-NP	O
goiter	goiter	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	IN	B-PP	O
CVA	CVA	NNP	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
mild	mild	JJ	B-NP	O
residual	residual	JJ	I-NP	O
right	right	JJ	I-NP	O
hemiparesis	hemiparesis	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Chronic	Chronic	JJ	B-NP	O
kidney	kidney	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
baseline	baseline	NN	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
1.9	1.9	CD	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
?	?	.	O	O

of	of	IN	B-PP	O
whether	whether	IN	B-SBAR	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
renal	renal	JJ	B-NP	O
tubular	tubular	JJ	I-NP	O
acidosis	acidosis	NN	I-NP	O
or	or	CC	I-NP	O
diabetes	diabetes	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
AT	AT	NN	I-NP	O
HOME	HOME	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

NPH	NPH	NN	B-NP	B-protein
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Plaquenil	Plaquenil	NN	B-NP	B-protein
200	200	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
b.i.d.	b.i.d.	RB	B-NP	I-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

Allopurinol	Allopurinol	DT	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Lisinopril	Lisinopril	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Paxil	Paxil	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Hydralazine	Hydralazine	NN	B-NP	B-protein
50	50	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
q.i.d.	q.i.d.	NN	I-NP	I-protein
7	7	CD	I-NP	I-protein
.	.	.	O	O

Toprol	Toprol	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Aspirin	Aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Imdur	Imdur	IN	B-PP	O
30	30	CD	B-NP	O
mg	mg	NN	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Prilosec	Prilosec	RB	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
,	,	,	O	O
11	11	CD	B-NP	O
.	.	.	O	O

Hydrochlorothiazide	Hydrochlorothiazide	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Calcitriol	Calcitriol	NN	B-NP	O
0.25	0.25	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-NP	O
13	13	CD	I-NP	O
.	.	.	O	O

Lipitor	Lipitor	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
To	To	TO	B-PP	O
metoclopramide	metoclopramide	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
causes	cause	VBZ	B-VP	O
dystonia	dystonia	NN	B-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
prior	prior	JJ	B-NP	O
tobacco	tobacco	NN	I-NP	O
history	history	NN	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
mom	mom	NN	I-NP	O
passed	pass	VBD	B-VP	O
away	away	RP	B-PRT	O
at	at	IN	B-PP	O
age	age	NN	B-NP	O
79	79	CD	I-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
diabetes	diabetes	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
father	father	NN	I-NP	O
passed	pass	VBD	B-VP	O
away	away	RP	B-PRT	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
age	age	NN	I-NP	O
of	of	IN	B-PP	O
66	66	CD	B-NP	O
from	from	IN	B-PP	O
an	an	DT	B-NP	O
aneurysm	aneurysm	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NN	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
temperature	temperature	NN	I-NP	O
was	be	VBD	B-VP	O
97.7	97.7	CD	B-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
of	of	IN	B-PP	O
93	93	CD	B-NP	O
,	,	,	O	O
respirations	respiration	NNS	B-NP	O
16	16	CD	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
151/69	151/69	CD	I-NP	O
,	,	,	O	O
satting	satte	VBG	B-VP	O
99	99	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
general	general	JJ	B-ADJP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
awake	awake	JJ	B-ADJP	O
,	,	,	O	O
alert	alert	JJ	B-ADJP	O
,	,	,	O	O
oriented	orient	VBN	B-VP	O
,	,	,	O	O
conversant	conversant	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
in	in	IN	B-PP	O
pain	pain	NN	B-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
Extraocular	Extraocular	JJ	B-NP	O
muscles	muscle	NNS	I-NP	O
were	be	VBD	B-VP	O
intact	intact	JJ	B-ADJP	O
,	,	,	O	O
mucous	mucous	JJ	B-NP	O
membranes	membrane	NNS	I-NP	O
are	be	VBP	B-VP	O
moist	moist	NN	B-NP	O
,	,	,	O	O
neck	neck	NN	B-NP	O
was	be	VBD	B-VP	O
supple	supple	NN	B-NP	O
,	,	,	O	O
JVP	JVP	NN	B-NP	B-protein
was	be	VBD	B-VP	O
not	not	RB	O	O
noticeably	noticeably	RB	B-ADJP	O
elevated	elevated	JJ	I-ADJP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
Regular	Regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
:	:	:	O	O
Clear	Clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
:	:	:	O	O
Soft	Soft	JJ	B-NP	O
,	,	,	I-NP	O
diffusely	diffusely	RB	I-NP	O
tender	tender	NN	I-NP	O
especially	especially	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
and	and	CC	I-NP	O
right	right	JJ	I-NP	O
lower	low	JJR	I-NP	O
quadrants	quadrant	NNS	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
question	question	NN	I-NP	O
of	of	IN	B-PP	O
rebound	rebound	NN	B-NP	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
distributions	distribution	NNS	I-NP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
Warm	Warm	NN	B-NP	O
and	and	CC	O	O
well	well	RB	B-VP	O
perfused	perfuse	VBN	I-VP	O
,	,	,	O	O
no	no	DT	B-NP	O
cyanosis/clubbing/edema	cyanosis/clubbing/edema	NN	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
Exquisite	Exquisite	JJ	B-NP	O
tenderness	tenderness	NN	I-NP	O
to	to	TO	B-PP	O
palpation	palpation	NN	B-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
hip	hip	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
severe	severe	JJ	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
could	could	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
positioned	position	VBN	I-VP	O
in	in	IN	B-PP	O
lateral	lateral	JJ	B-NP	O
decubitus	decubitus	NN	I-NP	O
position	position	NN	I-NP	O
to	to	TO	B-VP	O
accurately	accurately	RB	I-VP	O
assess	assess	VB	I-VP	O
for	for	IN	B-PP	O
bursal	bursal	JJ	B-NP	O
pain	pain	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
positive	positive	JJ	B-NP	O
left	left	JJ	I-NP	O
hip	hip	NN	I-NP	O
pain	pain	NN	I-NP	O
on	on	IN	B-PP	O
internal	internal	JJ	B-NP	O
and	and	CC	I-NP	O
external	external	JJ	I-NP	O
rotation	rotation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hip	hip	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
positive	positive	JJ	B-NP	B-protein
left	left	JJ	I-NP	I-protein
elbow	elbow	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
,	,	,	O	O
along	along	IN	B-PP	O
with	with	IN	B-PP	O
pain	pain	NN	B-NP	O
in	in	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
other	other	JJ	I-NP	O
areas	area	NNS	I-NP	O
,	,	,	O	O
without	without	IN	B-PP	O
obvious	obvious	JJ	B-NP	O
erythema	erythema	NN	I-NP	O
,	,	,	O	O
effusion	effusion	NN	B-NP	O
,	,	,	O	O
warmth	warmth	NN	B-NP	O
or	or	CC	I-NP	O
trauma	trauma	NN	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
STUDIES	STUDIES	VBZ	B-VP	O
ON	ON	NN	B-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
sodium	sodium	NN	I-NP	O
was	be	VBD	B-VP	O
130	130	CD	B-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
of	of	IN	B-PP	O
4.1	4.1	CD	B-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
of	of	IN	B-PP	O
99	99	CD	B-NP	O
,	,	,	O	O
bicarb	bicarb	NN	B-NP	O
of	of	IN	B-PP	O
22	22	CD	B-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	O
of	of	IN	B-PP	O
78	78	CD	B-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
of	of	IN	B-PP	O
2.3	2.3	CD	B-NP	O
-LRB-	-LRB-	SYM	I-NP	O
baseline	baseline	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
1.9-2	1.9-2	CD	I-NP	O
.5	.5	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
of	of	IN	B-PP	O
227	227	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
white	white	JJ	I-NP	O
count	count	NN	I-NP	O
was	be	VBD	B-VP	O
11.8	11.8	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	O
of	of	IN	B-PP	O
26.9	26.9	CD	B-NP	O
-LRB-	-LRB-	SYM	I-NP	O
baseline	baseline	NN	I-NP	O
hematocrit	hematocrit	NN	I-NP	O
of	of	IN	B-PP	O
29-30	29-30	CD	B-NP	O
-RRB-	-RRB-	HYPH	B-ADJP	O
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-cell_type
of	of	IN	B-PP	O
378	378	CD	B-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
ALT	ALT	NN	I-NP	B-protein
was	be	VBD	B-VP	O
12	12	CD	B-NP	O
,	,	,	O	O
AST	AST	NN	B-NP	O
was	be	VBD	B-VP	O
12	12	CD	B-NP	O
,	,	,	O	O
alkaline	alkaline	JJ	B-NP	B-protein
phosphatase	phosphatase	NN	I-NP	I-protein
of	of	IN	B-PP	O
98	98	CD	B-NP	O
,	,	,	O	O
total	total	JJ	B-NP	O
bilirubin	bilirubin	NN	I-NP	O
0.2	0.2	CD	I-NP	O
,	,	,	O	O
albumin	albumin	NN	B-NP	B-protein
was	be	VBD	B-VP	O
3.1	3.1	CD	B-NP	O
and	and	CC	O	O
globulin	globulin	NN	B-NP	B-protein
was	be	VBD	B-VP	O
4.2	4.2	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
ESR	ESR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
103	103	CD	B-NP	O
,	,	,	O	O
CRP	CRP	NN	B-NP	B-protein
was	be	VBD	B-VP	O
151	151	CD	B-NP	O
.	.	.	O	O

OTHER	OTHER	NNP	B-NP	O
PERTINENT	PERTINENT	NNP	I-NP	O
LABS	LABS	NNP	I-NP	O
DURING	DURING	NNP	I-NP	O
THE	THE	DT	B-NP	O
COURSE	COURSE	NNP	I-NP	O
OF	OF	IN	B-PP	O
HER	HER	NNP	B-NP	O
HOSPITALIZATION	HOSPITALIZATION	NN	I-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
initial	initial	JJ	I-NP	O
urine	urine	NN	I-NP	O
sodium	sodium	NN	I-NP	O
was	be	VBD	B-VP	O
34	34	CD	B-NP	O
,	,	,	O	O
urine	urine	NN	B-NP	O
creatinine	creatinine	NN	I-NP	O
58.2	58.2	CD	I-NP	O
,	,	,	O	O
urine	urine	NN	B-NP	O
BUN	BUN	NN	I-NP	O
555	555	CD	I-NP	O
;	;	:	O	O
urine	urine	NN	B-NP	O
eosinophils	eosinophil	VBZ	B-VP	O
negative	negative	JJ	B-ADJP	O
;	;	:	O	O
urinalysis	urinalysis	NN	B-NP	O
showed	show	VBD	B-VP	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
protein	protein	NN	I-NP	O
,	,	,	O	O
23	23	CD	B-NP	O
white	white	JJ	I-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
red	red	JJ	I-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
bacteria	bacteria	NNS	I-NP	O
and	and	CC	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
squamous	squamous	JJ	I-NP	O
cells	cell	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
10/3/07	10/3/07	CD	B-NP	O
,	,	,	O	O
urine	urine	NN	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
and	and	CC	O	O
blood	blood	NN	B-NP	O
cultures	culture	NNS	I-NP	O
negative	negative	JJ	B-ADJP	O
;	;	:	O	O
8/28/07	8/28/07	CD	B-NP	O
urine	urine	NN	I-NP	O
culture	culture	NN	I-NP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
MRSA	MRSA	NN	B-NP	B-protein
,	,	,	O	O
sensitive	sensitive	JJ	B-ADJP	O
to	to	TO	B-PP	O
Bactrim	Bactrim	NNP	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
3/8/07	3/8/07	CD	B-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
hip	hip	NN	B-NP	O
washing	washing	NN	I-NP	O
and	and	CC	O	O
aspiration	aspiration	NN	B-NP	O
Gram-stain	Gram-stain	NN	I-NP	O
negative	negative	JJ	B-ADJP	O
and	and	CC	O	O
culture	culture	NN	B-ADJP	O
negative	negative	JJ	I-ADJP	O
.	.	.	O	O

On	On	IN	B-PP	O
7/25/07	7/25/07	CD	B-NP	O
,	,	,	O	O
C.	C.	NNP	B-NP	O
difficile	difficile	VBP	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

HER	HER	NN	B-NP	O
RELEVANT	RELEVANT	NN	I-NP	O
STUDIES	STUDIES	NN	I-NP	O
ARE	ARE	NN	I-NP	O
AS	AS	NN	I-NP	O
FOLLOWS	FOLLOWS	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
10/3/07	10/3/07	CD	B-NP	O
,	,	,	O	O
pelvic	pelvic	JJ	B-NP	O
and	and	CC	I-NP	O
hip	hip	NN	I-NP	O
x-rays	x-ray	NNS	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
right	right	JJ	B-NP	O
hip	hip	NN	I-NP	O
rheumatoid	rheumatoid	JJ	I-NP	O
arthritis	arthritis	NN	I-NP	O
,	,	,	O	O
narrowing	narrow	VBG	B-VP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
SI	SI	NN	I-NP	O
joint	joint	NN	I-NP	O
;	;	:	O	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
abnormality	abnormality	NN	I-NP	O
or	or	CC	I-NP	O
effusion	effusion	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
hip	hip	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
10/3/07	10/3/07	CD	B-NP	O
,	,	,	O	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
noninvasive	noninvasive	JJ	I-NP	O
studies	study	NNS	I-NP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

On	On	IN	B-PP	O
10/3/07	10/3/07	CD	B-NP	O
,	,	,	O	O
KUB	KUB	NN	B-NP	B-protein
showing	show	VBG	B-VP	O
gastric	gastric	JJ	B-NP	O
antral	antral	JJ	I-NP	O
gas	gas	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
10/3/07	10/3/07	CD	B-NP	O
abdominal	abdominal	JJ	I-NP	O
CAT	CAT	NN	I-NP	O
scan	scan	NN	I-NP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
bilateral	bilateral	JJ	B-NP	B-protein
peri	peri	NN	I-NP	I-protein
renal	renal	JJ	I-NP	I-protein
straining	straining	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
old	old	JJ	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
mesenteric	mesenteric	JJ	B-NP	O
stranding	stranding	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
old	old	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
phlebolith	phlebolith	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
3/8/07	3/8/07	CD	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
,	,	,	O	O
EF	EF	NN	B-NP	B-protein
of	of	IN	B-PP	O
60	60	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
concentric	concentric	JJ	B-NP	O
left	left	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
mitral	mitral	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
tricuspid	tricuspid	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
,	,	,	O	O
pulmonary	pulmonary	JJ	B-NP	O
artery	artery	NN	I-NP	O
systolic	systolic	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
38	38	CD	B-NP	O
plus	plus	CC	O	O
right	right	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
,	,	,	O	O
trace	trace	NN	B-NP	O
effusion	effusion	NN	I-NP	O
.	.	.	O	O

ASSESSMENT	ASSESSMENT	NN	B-NP	O
AND	AND	CC	I-NP	O
PLAN	PLAN	NN	I-NP	O
:	:	:	O	O
A	A	DT	B-NP	O
65-year-old	65-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
rheumatoid	rheumatoid	NN	B-NP	O
and	and	CC	I-NP	O
gouty	gouty	NN	I-NP	O
arthritis	arthritis	NN	I-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
sickle	sickle	NN	B-NP	O
cell	cell	NN	I-NP	O
trait	trait	NN	I-NP	O
and	and	CC	O	O
chronic	chronic	JJ	B-NP	O
kidney	kidney	NN	I-NP	O
disease	disease	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
baseline	baseline	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
1.9	1.9	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
admitted	admit	VBN	B-VP	O
for	for	IN	B-PP	O
diffuse	diffuse	JJ	B-NP	O
body	body	NN	I-NP	O
aches	ache	NNS	I-NP	O
and	and	CC	I-NP	O
pains	pain	NNS	I-NP	O
,	,	,	O	O
most	most	RBS	B-ADVP	O
likely	likely	RB	I-ADVP	O
attributable	attributable	JJ	B-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
rheumatoid	rheumatoid	JJ	I-NP	O
arthritis	arthritis	NN	I-NP	O
flare	flare	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Body	Body	JJ	B-NP	O
aches	ache	NNS	I-NP	O
and	and	CC	O	O
joint	joint	JJ	B-NP	O
pains	pain	NNS	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
differential	differential	JJ	I-NP	O
diagnosis	diagnosis	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
body	body	NN	I-NP	O
aches	ache	NNS	I-NP	O
and	and	CC	O	O
joint	joint	JJ	B-NP	O
pains	pain	NNS	I-NP	O
initially	initially	RB	B-ADVP	O
included	include	VBD	B-VP	O
a	a	DT	B-NP	O
rheumatoid	rheumatoid	JJ	I-NP	O
arthritis	arthritis	NN	I-NP	O
flare	flare	NN	I-NP	O
,	,	,	O	O
septic	septic	JJ	B-NP	O
joint	joint	NN	I-NP	O
,	,	,	O	O
crystal	crystal	JJ	B-NP	O
joint	joint	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
intra-abdominal	intra-abdominal	JJ	B-NP	O
process	process	NN	I-NP	O
or	or	CC	O	O
Plaquenil	Plaquenil	NN	B-NP	O
reaction	reaction	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
abdominal	abdominal	JJ	I-NP	O
CAT	CAT	NN	I-NP	O
scan	scan	NN	I-NP	O
showed	show	VBD	B-VP	O
stable	stable	JJ	B-NP	O
peri-renal	peri-renal	JJ	I-NP	O
standing	standing	NN	I-NP	O
and	and	CC	O	O
mesenteric	mesenteric	JJ	B-NP	O
stranding	stranding	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	B-cell_line
urine	urine	NN	I-NP	I-cell_line
culture	culture	NN	I-NP	I-cell_line
from	from	IN	B-PP	O
the	the	DT	B-NP	O
second	second	JJ	I-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
hospitalization	hospitalization	NN	B-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
MRSA	MRSA	NN	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
left	left	JJ	I-NP	O
hip	hip	NN	I-NP	O
aspiration	aspiration	NN	I-NP	O
was	be	VBD	B-VP	O
attempted	attempt	VBN	I-VP	O
by	by	IN	B-PP	O
Interventional	Interventional	JJ	B-NP	O
Radiology	Radiology	NN	I-NP	O
;	;	:	O	O
no	no	DT	B-NP	O
fluid	fluid	NN	I-NP	O
was	be	VBD	B-VP	O
obtainable	obtainable	JJ	B-ADJP	O
,	,	,	O	O
so	so	IN	O	O
a	a	DT	B-NP	O
washing	washing	NN	I-NP	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
drainage	drainage	NN	B-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
,	,	,	O	O
which	which	WDT	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
negative	negative	JJ	I-NP	O
Gram-stain	Gram-stain	NNP	I-NP	O
and	and	CC	O	O
negative	negative	JJ	B-NP	O
cultures	culture	NNS	I-NP	O
.	.	.	O	O

Similarly	Similarly	RB	B-ADVP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
cultures	culture	NNS	I-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
an	an	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
endocarditis	endocarditis	NN	B-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
explanation	explanation	NN	I-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
MRSA	MRSA	NN	I-NP	O
urinary	urinary	JJ	I-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

By	By	IN	B-PP	O
process	process	NN	B-NP	O
of	of	IN	B-PP	O
elimination	elimination	NN	B-NP	O
,	,	,	O	O
therefore	therefore	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
etiology	etiology	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
body	body	NN	I-NP	O
aches	ache	NNS	I-NP	O
and	and	CC	O	O
joint	joint	JJ	B-NP	O
pains	pain	NNS	I-NP	O
was	be	VBD	B-VP	O
therefore	therefore	RB	I-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
rheumatoid	rheumatoid	JJ	B-NP	O
arthritis	arthritis	NN	I-NP	O
flare	flare	NN	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
of	of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
ESR	ESR	NN	I-NP	B-protein
and	and	CC	I-NP	O
CRP	CRP	NN	I-NP	B-protein
were	be	VBD	B-VP	O
a	a	DT	B-NP	O
bit	bit	RB	I-NP	O
higher	high	JJR	B-ADJP	O
than	than	IN	B-SBAR	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
expected	expect	VBN	I-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
rheumatoid	rheumatoid	JJ	I-NP	O
arthritis	arthritis	NN	I-NP	O
flare	flare	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Rheumatology	Rheumatology	NNP	I-NP	O
Consult	Consult	NNP	I-NP	O
Service	Service	NNP	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
stated	state	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
Plaquenil	Plaquenil	NNP	I-NP	O
would	would	MD	B-VP	O
take	take	VB	I-VP	O
a	a	DT	B-NP	O
few	few	JJ	I-NP	O
weeks	week	NNS	I-NP	O
to	to	TO	B-VP	O
exert	exert	VB	I-VP	O
its	its	PRP$	B-NP	O
effect	effect	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-PP	O
a	a	DT	B-NP	O
result	result	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
prednisone	prednisone	NN	B-NP	O
and	and	CC	O	O
uptitrated	uptitrate	VBN	B-VP	O
per	per	IN	B-PP	O
symptoms	symptom	NNS	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
leflunomide	leflunomide	NN	B-NP	O
.	.	.	O	O

Initially	Initially	RB	B-ADVP	O
,	,	,	O	O
there	there	EX	B-NP	O
were	be	VBD	B-VP	O
plans	plan	NNS	B-NP	O
to	to	TO	B-VP	O
start	start	VB	I-VP	O
Enbrel	Enbrel	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
PPD	PPD	NN	I-NP	B-protein
placed	place	VBN	B-VP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
concomitant	concomitant	JJ	I-NP	O
MRSA	MRSA	NN	I-NP	O
urinary	urinary	JJ	I-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
,	,	,	O	O
such	such	JJ	B-NP	O
plans	plan	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
deferred	defer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
setting	setting	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

MRSA	MRSA	NN	B-NP	O
urinary	urinary	JJ	I-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
:	:	:	O	O
As	As	IN	B-SBAR	O
discussed	discuss	VBN	B-VP	O
above	above	IN	B-PP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
urine	urine	NN	I-NP	O
culture	culture	NN	I-NP	O
day	day	NN	I-NP	O
after	after	IN	B-SBAR	O
admission	admission	NN	B-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
MRSA	MRSA	NN	B-NP	B-protein
,	,	,	O	O
sensitive	sensitive	JJ	B-ADJP	O
to	to	TO	B-PP	O
Bactrim	Bactrim	NNP	B-NP	O
.	.	.	O	O

Due	Due	JJ	B-ADJP	O
to	to	TO	B-VP	O
hip	hip	VB	I-VP	O
pain	pain	NN	B-NP	O
and	and	CC	O	O
one	one	CD	B-NP	O
mild	mild	JJ	I-NP	O
fever	fever	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
100.6-100	100.6-100	CD	B-NP	O
.9	.9	CD	I-NP	O
with	with	IN	B-PP	O
persistent	persistent	JJ	B-NP	O
leukocytosis	leukocytosis	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
11	11	CD	B-NP	O
to	to	TO	B-PP	O
15	15	CD	B-NP	O
,	,	,	O	O
Interventional	Interventional	NNP	B-NP	O
Radiology	Radiology	NNP	I-NP	O
did	do	VBD	B-VP	O
a	a	DT	B-NP	O
hip	hip	NN	I-NP	O
wash	wash	NN	I-NP	O
and	and	CC	I-NP	O
aspirate	aspirate	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
transthoracic	transthoracic	JJ	I-NP	O
echo	echo	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
endocarditis	endocarditis	NN	B-NP	O
.	.	.	O	O

Surveillance	Surveillance	NN	B-NP	O
blood	blood	NN	I-NP	O
cultures	culture	NNS	I-NP	O
similarly	similarly	RB	B-ADVP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
plans	plan	NNS	B-NP	O
to	to	TO	B-VP	O
change	change	VB	I-VP	O
to	to	TO	B-PP	O
Bactrim	Bactrim	NNP	B-NP	O
upon	upon	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Pain	Pain	NN	B-NP	O
control	control	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
standing	standing	NN	B-NP	O
and	and	CC	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
Dilaudid	Dilaudid	NNP	I-NP	O
,	,	,	O	O
along	along	IN	B-PP	O
with	with	IN	B-PP	O
OxyContin	OxyContin	NN	B-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
latter	latter	JJ	I-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
refused	refuse	VBD	B-VP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
nausea	nausea	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
,	,	,	O	O
therefore	therefore	RB	B-ADVP	O
,	,	,	O	O
started	start	VBD	B-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
fentanyl	fentanyl	NN	I-NP	O
patch	patch	NN	I-NP	O
with	with	IN	B-PP	O
standing	standing	NN	B-NP	O
and	and	CC	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
Dilaudid	Dilaudid	NNP	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
well	well	RB	B-ADVP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
standing	standing	NN	I-NP	O
and	and	CC	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
Dilaudid	Dilaudid	NNP	I-NP	O
.	.	.	O	O

As	As	IN	B-PP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
done	do	VBN	I-VP	O
well	well	RB	B-ADVP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
hypertensive	hypertensive	JJ	B-ADJP	O
with	with	IN	B-PP	O
systolic	systolic	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
170s	170	NNS	B-NP	O
at	at	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
times	time	NNS	I-NP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
partly	partly	RB	B-ADVP	O
from	from	IN	B-PP	O
pain	pain	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
partly	partly	RB	B-ADVP	O
from	from	IN	B-PP	O
poor	poor	JJ	B-NP	O
control	control	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
central	central	JJ	I-NP	O
hypertension	hypertension	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
Toprol	Toprol	NNP	B-NP	O
,	,	,	I-NP	O
Imdur	Imdur	NNP	I-NP	O
,	,	,	I-NP	O
hydralazine	hydralazine	NN	I-NP	O
and	and	CC	I-NP	O
amlodipine	amlodipine	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
titrated	titrate	VBN	I-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
maximum	maximum	NN	I-NP	O
effect	effect	NN	I-NP	O
.	.	.	O	O

Because	Because	IN	B-PP	O
of	of	IN	I-PP	O
refractory	refractory	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
recommend	recommend	VBP	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
undergo	undergo	VBP	B-VP	O
renal	renal	JJ	B-NP	O
artery	artery	NN	I-NP	O
imaging	imaging	NN	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Diabetes	Diabete	NNS	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
NPH	NPH	NN	B-NP	B-protein
,	,	,	O	O
short-acting	short-acting	JJ	B-NP	B-protein
prandial	prandial	JJ	I-NP	I-protein
insulin	insulin	NN	I-NP	I-protein
and	and	CC	O	O
a	a	DT	B-NP	O
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
,	,	,	O	O
all	all	DT	B-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
up	up	RB	I-VP	O
titrated	titrate	VBN	I-VP	O
while	while	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
inhouse	inhouse	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Acute	Acute	JJ	B-ADJP	O
on	on	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
acute	acute	JJ	B-ADJP	O
on	on	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
2.3	2.3	CD	I-NP	O
,	,	,	O	O
baseline	baseline	NN	B-NP	O
of	of	IN	B-PP	O
1.9	1.9	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
predominantly	predominantly	RB	B-ADJP	O
prerenal	prerenal	JJ	I-ADJP	O
.	.	.	O	O

Through	Through	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
gradually	gradually	RB	B-ADVP	O
decreased	decrease	VBD	B-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
of	of	IN	B-PP	O
1.9	1.9	CD	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
A	A	DT	B-NP	O
separate	separate	JJ	I-NP	O
dictation	dictation	NN	I-NP	O
for	for	IN	B-PP	O
medication	medication	NN	B-NP	O
list	list	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
supplied	supply	VBN	I-VP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
ready	ready	JJ	B-ADJP	O
for	for	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
6-0706017	6-0706017	CD	B-NP	O
CSSten	CSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
CANOY	CANOY	NNP	B-NP	O
,	,	,	O	O
IRVING	IRVING	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
BOZZO	BOZZO	NN	B-NP	B-protein
,	,	,	O	O
CLEVELAND	CLEVELAND	NN	B-NP	O
Dictation	Dictation	NN	I-NP	O
ID	ID	NN	I-NP	O
9360983	9360983	CD	I-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
7/28/07	7/28/07	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
7/28/07	7/28/07	CD	B-NP	O

